Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A Medical Research Council report

Journal of Clinical Oncology

Volumn 14, Issue 4, 1996, Pages 1106-1113

  Cullen, M H ^a   Stenning, S P ^a   Parkinson, M C ^a   Fossa, S D ^a   Kaye, S B ^a   Horwich, A H ^a   Harland, S J ^a   Williams, M V ^a   Jakes, R ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; GASTROINTESTINAL TOXICITY; GERM CELL TUMOR; HIGH RISK PATIENT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECOND CANCER; TESTIS TUMOR; TREATMENT OUTCOME;

EID: 0029866244     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.4.1106     Document Type: Article

References (32)

1. Cullen MH: Management of stage I non-seminoma: Surveillance and chemotherapy, in Horwich A (ed): Testicular Cancer Investigation and Management. London, United Kingdom, Chapman and Hall Medical, 1991, pp 149-166
2. McLeod DG, Weiss RB, Stablein DM, et al: Staging relationships and outcome in early stage testicular cancer. A report from the Testicular Cancer Intergroup Study. J Urol 145:1178-1183, 1991
3. Moynihan C: Testicular cancer: The psychosocial problems of patients and their relatives. Cancer Surv 6:477-510, 1987
4. Freedman LS, Parkinson MC, Jones WG, et al: Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet ii:294-298, 1987
5. Read G, Stenning SP, Cullen MH, et al: Medical Research Council Prospective study of surveillance for stage I testicular teratoma. J Clin Oncol 10:1762-1768, 1992
6. Williams SD, Stablein DM, Einhorn LH, et al: Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 317:1433-1438, 1987
7. Stuart NSA, Woodroffe CM, Grundy R, et al: Long-term side-effects of chemotherapy for testicular cancer: The cost of cure. Br J Cancer 61:479-484, 1990
8. Herson J: Predictive probability early termination plans for phase II clinical trials. Biometrics 34:775-783, 1979
9. Pugh RCB, Cameron KM: Teratoma, in Pugh RCB (ed): Pathology of the Testis. Oxford, United Kingdom, Blackwell, 1976, pp 199-244
10. Peckham MJ, Barrett A, Husband JE, et al: Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet 2:678-680, 1982
11. Pizzocaro G, Zanoni F, Salvioni R, et al: Difficulties of surveillance study omitting retroperitoneal lymphadenectomy in clinical I nonseminomatous germ cell tumours of the testis. J Urol 138:1393-1396, 1987
12. Aass N, Fossa SD, Ous S, et al: Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer? Br J Urol 65:385-390, 1990
13. Moriyama N, Daly JJ, Keating MA, et al: Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumours of the testis. Cancer 56:2492-2498, 1985
14. Javadpour N, Young D Jr: Prognostic factors in nonseminomatous testicular cancer. J Urol 135:497-499, 1986
15. Dunphy CH, Ayala AG, Swabson DA, et al: Clinical stage I nonseminomatous and mixed germ cell tumour of the testis. Cancer 62:1202-1206, 1988
16. Rodriguez PN, Hafez GR, Messing EM: Nonseminomatous germ cell tumour of the testicle: Does extensive staging of the primary tumour predict the likelihood of metastatic disease? J Urol 136:604-608, 1986
17. Fung CY, Kalish LA, Brodsky GL, et al: Stage I nonseminomatous germ cell testicular tumor. Prediction of metastatic potential by primary histopathology. J Clin Oncol 6:1467-1473, 1988
18. Hoskin P, Duly S, Easton D, et al: Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchidectomy and surveillance: Implications for adjuvant chemotherapy. J Clin Oncol 4:1031-1036, 1986
19. Pont J, Holtl W, Kosak D, et al: Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: A prospective trial. J Clin Oncol 8:16-20, 1990
20. Oliver RTD, Raja MA, Ong J, Gallagher CJ: Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage I malignant teratoma on overall relapse rate of stage 1 cancer patients. J Urol 148:1453-1456, 1992
21. Studer UE, Fey MF, Calderoni A, et al: Adjuvant chemotherapy after orchidectomy in high-risk patients with clinical stage I non-seminotous testicular cancer. Eur Urol 23:444-449, 1993
22. Koocher GP, O'Malley JE: The Damocles syndrome: Psychosocial consequences of surviving childhood cancer. New York, NY, McGraw-Hill, 1981
23. Howard GCW, Clarke K, Elia MH, et al: A Scottish national audit of current patterns of management for patients with testicular non-seminomatous germ cell tumours. Br J Cancer 72:1303-1306, 1995
24. Vugrin D, Peckham MJ, Pizzocaro G, et al: Multinational experience with orchidectomy alone in the treatment of clinical stage I nonseminomatus tumors, in Jones SE, Salmon SE (eds): Adjuvant Therapy of Cancer IV. Philadelphia, PA, Grune & Stratton, 1984, pp 521-527
25. Sogani PC, Whitmore WF Jr, Herr HW, et al: Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. J Clin Oncol 2:267-270, 1984
26. Cullen MH, Cook J, Woodroffe C, et al: Surveillance or immediate adjuvant chemotherapy for stage I non-seminomatous germ cell tumours of the testis (NSGCTT). Br J Cancer 69:14, 1994 (suppl 21; abstr)
27. Doll DC, List AF, Greco FA, et al: Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ cell tumours of the testis. Ann Int Med 105:48-51, 1986
28. Gerl A, Clemm C, Wilmanns W: Acute cerebrovascular event after cisplatin-based chemotherapy for testicular cancer. Lancet 338:385, 1991 (letter)
29. Nichols C, Roth B, Williams S, et al: Cardiovascular complications of chemotherapy for testicular cancer. Proc Am Soc Clin Oncol 9:132, 1990 (abstract 512)
30. Pedersen-Bjergaard J, Daugaard G, Hansen SW, et al: Increased risk of myelodysplasia for germ cell tumours. Lancet 338:359-363, 1991
31. Nichols CR, Breeden ES, Loehrer PJ, et al. Secondary leukemia associated with a conventional dose of etoposide: Review of serial germ cell tumour protocols. J Natl Cancer Inst 85:36-40, 1993
32. Bokemeyer C, Schmoll H-J: Secondary neoplasms following treatment of malignant germ cell tumors. J Clin Oncol 11:1703-1709, 1993